SCHEMBL14099253

SCHEMBL14099253

c1ccc(N(c2ccc3ccccc3c2)c2ccc(N(c3ccccc3)c3cccc4ccccc34)c3nc4ccccc4nc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.36
SIGMAR1 Q99720 5/20 0.35
MAOA P21397 1/20 0.35
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
ALDH1A1 P00352 2/20 0.31
NPC1 O15118 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
PTBP1 P26599 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31
RCE1 Q9Y256 1/20 0.31
KDM1A O60341 4/20 0.31
NQO2 P16083 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP1B1 Q16678 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14099422 0.91 SIGMAR1 (0.40) KDM4ESIGMAR1MAOAESR1ESR2
SCHEMBL14099250 0.90 SIGMAR1 (0.35) KDM4ESIGMAR1ALDH1A1HIF1ACYP1A2
SCHEMBL14099523 0.89 NQO2 (0.38) KDM4EESR1ESR2ALDH1A1LMNA
SCHEMBL14099374 0.89 SIGMAR1 (0.41) KDM4ESIGMAR1MAOAESR1ESR2
SCHEMBL14099423 0.89 NQO2 (0.38) KDM4EESR1ESR2ALDH1A1LMNA
SCHEMBL17468436 0.86 SIGMAR1 (0.43) KDM4ESIGMAR1ALDH1A1HIF1ACYP1B1
SCHEMBL24702723 0.85 SIGMAR1 (0.42) KDM4ESIGMAR1ALDH1A1HIF1ACYP1B1
SCHEMBL4887864 0.85 SIGMAR1 (0.42) KDM4ESIGMAR1ALDH1A1HIF1ACYP1B1
SCHEMBL30343585 0.85 SIGMAR1 (0.42) KDM4ESIGMAR1ALDH1A1HIF1ACYP1B1
SCHEMBL13766335 0.85 SIGMAR1 (0.42) KDM4ESIGMAR1ALDH1A1HIF1ACYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1956011-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2008-08-13 EP disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070132372-A1 AMINE BASED COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KCNH2, SLC7A5, KCNH3 KDM4E 1016/4885SIGMAR1 2031/4885MAOA 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.